Revive Infusion Bar
- Vitamin IV Therapy
- IV Therapy
- IV Hydration
- Semaglutide
- Tirzepatide
United States
This is the national page for tirzepatide on Regenerated.com, listing clinics across the United States whose own websites name tirzepatide as a service. Tirzepatide is a once weekly injectable prescription medicine made by Eli Lilly and Company that activates two hormone receptors, GIP and GLP-1. In the US it is sold as Mounjaro, for type 2 diabetes, and as Zepbound, for chronic weight management and obstructive sleep apnea in adults with obesity. Some clinics prescribe one of these brands, some prescribe a compounded preparation made by a pharmacy, and some offer both. A listing here does not tell you which.
The labels set out what each brand is approved for. Mounjaro is labeled for blood sugar control in adults and children 10 years and older with type 2 diabetes, and for reducing the risk of major cardiovascular events in adults with type 2 diabetes at high risk for those events. Zepbound is labeled, together with a reduced calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity, or overweight with at least one weight related condition, and to treat moderate to severe obstructive sleep apnea in adults with obesity. The Zepbound label states that combining it with other tirzepatide products or any GLP-1 receptor agonist "is not recommended," so Mounjaro and Zepbound are one molecule under two names, not two drugs to combine.
Compounded tirzepatide is a different matter. The FDA states that "compounded drugs are not FDA approved" and that it does not review them for safety, effectiveness or quality before they are marketed. The FDA declared the tirzepatide injection shortage resolved on December 19, 2024, which changed the rules for compounders.
Both labels carry a boxed warning about thyroid C-cell tumors seen in rats, and both list a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) as a contraindication. The full warnings, contraindications and adverse reactions are in each label's prescribing information, and a prescriber should go through them with you against your own history.
Before booking anywhere, ask which product will be prescribed: Mounjaro, Zepbound or a compounded preparation, and under which labeled use. Ask whether the prescription goes to LillyDirect, a retail pharmacy or a compounding pharmacy, and confirm that pharmacy's license with your state board of pharmacy. Ask for the prescriber's full name and credentials and check the license yourself. Ask who reviews your history against the boxed warning, how dose changes and follow up are handled, and who you contact between visits. A clear quote lists the visit or membership fee separately from the medicine.
This national list is not for sale. Organic order is never paid ranking, Featured slots are labeled and capped, and Verified means the clinic completed credential checks, not that it spent money. Regenerated.com is free for patients, and inclusion in the directory is not an endorsement. Use the state hubs below the list to turn this nationwide view into a shortlist closer to you.
For the labels, trials and costs in more depth, read the tirzepatide guide, and for the rules on pharmacy made versions, read compounded tirzepatide. Two short explainers cover how listings work here: How to read a Regenerated city hub and Featured vs Verified vs organic.
Explore by state